Immune modulation by inhibitors of the HO system | ||
| dc.conicet.organizacion | Pontificia Universidad Católica de Chile | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - San Luis. Instituto Multidisciplinario de Investigaciones Biológicas de San Luis. Universidad Nacional de San Luis. Facultad de Ciencias Físico Matemáticas y Naturales. Instituto Multidisciplinario de Investigaciones Biológicas de San Luis | |
| dc.conicet.organizacion | Pontificia Universidad Católica de Chile | |
| dc.conicet.organizacion | Pontificia Universidad Católica de Chile | |
| dc.conicet.organizacion | Pontificia Universidad Católica de Chile | |
| dc.conicet.organizacion | Pontificia Universidad Católica de Chile | |
| dc.contributor.author | Fernández Fierro, Ayleen | |
| dc.contributor.author | Funes, Samanta Celeste | |
| dc.contributor.author | Rios, Mariana | |
| dc.contributor.author | Covián, Camila | |
| dc.contributor.author | González, Jorge | |
| dc.contributor.author | Kalergis, Alexis M. | |
| dc.date.issued | 2021-01 | |
| dc.description.abstract | The heme oxygenase (HO) system involves three isoforms of this enzyme, HO-1, HO-2, and HO-3. The three of them display the same catalytic activity, oxidating the heme group to produce biliverdin, ferrous iron, and carbon monoxide (CO). HO-1 is the isoform most widely studied in proinflammatory diseases because treatments that overexpress this enzyme promote the generation of anti-inflammatory products. However, neonatal jaundice (hyperbilirubinemia) derived from HO overexpression led to the development of inhibitors, such as those based on metaloproto-and meso-porphyrins inhibitors with competitive activity. Further, non-competitive inhibitors have also been identified, such as synthetic and natural imidazole-dioxolane-based, small synthetic molecules, inhibitors of the enzyme regulation pathway, and genetic engineering using iRNA or CRISPR cas9. Despite most of the applications of the HO inhibitors being related to metabolic diseases, the beneficial effects of these molecules in immune-mediated diseases have also emerged. Different medical implications, including cancer, Alzheimer´s disease, and infections, are discussed in this article and as to how the selective inhibition of HO isoforms may contribute to the treatment of these ailments. | es |
| dc.description.fil | Fil: Fernández Fierro, Ayleen. Pontificia Universidad Católica de Chile; Chile | |
| dc.description.fil | Fil: Funes, Samanta Celeste. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - San Luis. Instituto Multidisciplinario de Investigaciones Biológicas de San Luis. Universidad Nacional de San Luis. Facultad de Ciencias Físico Matemáticas y Naturales. Instituto Multidisciplinario de Investigaciones Biológicas de San Luis; Argentina | |
| dc.description.fil | Fil: Rios, Mariana. Pontificia Universidad Católica de Chile; Chile | |
| dc.description.fil | Fil: Covián, Camila. Pontificia Universidad Católica de Chile; Chile | |
| dc.description.fil | Fil: González, Jorge. Pontificia Universidad Católica de Chile; Chile | |
| dc.description.fil | Fil: Kalergis, Alexis M.. Pontificia Universidad Católica de Chile; Chile | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Fernández Fierro, Ayleen; Funes, Samanta Celeste; Rios, Mariana; Covián, Camila; González, Jorge; et al.; Immune modulation by inhibitors of the HO system; MDPI AG; International Journal of Molecular Sciences; 22; 1; 1-2021; 1-18; 294 | es |
| dc.identifier.eissn | 1422-0067 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1661-6596 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/137035 | |
| dc.journal.number | 1 | es |
| dc.journal.pagination | 1-18; 294 | es |
| dc.journal.pais | Suiza | es |
| dc.journal.title | International Journal of Molecular Sciences | es |
| dc.journal.volume | 22 | es |
| dc.language.iso | eng | es |
| dc.publisher | MDPI AG | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/1422-0067/22/1/294 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3390/ijms22010294 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | HEME OXYGENASE-1 | es |
| dc.subject | HEME OXYGENASE-2 | es |
| dc.subject | INHIBITORS | es |
| dc.subject | IMMUNOMODULATION | es |
| dc.subject | INFECTIONS | es |
| dc.subject | CANCER | es |
| dc.subject.classification | Inmunología | es |
| dc.subject.classification | Medicina Básica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Immune modulation by inhibitors of the HO system | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.22b1c316-7bbb-47e8-b2ea-b647f3aa3a31_A.pdf
- Tamaño:
- 1.79 MB
- Formato:
- Adobe Portable Document Format